Single arketamine in treatment resistant depression: Presentation of 3 cases with regard to sick-leave duration
{{output}}
Background: Ketamine is the prototypal rapid-acting antidepressant (RAAD) for TRD with approved indication for esketamine-nasal spray (ESK-NS). Distinctly, arketamine (R-KET) demonstrates enhanced antidepressant effects and neuro... ...
